Nuevocor
PrivateLast Round
Series B
May 6, 2025
Total Funding Raised
$69M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nuevocor is a biotechnology company that develops gene therapies for cardiomyopathies driven by aberrant mechanobiology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nuevocor Comparables
Compare Nuevocor with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Affinia Therapeutics | 79% | |
| DiNAQOR AG | 76% | |
| Bayer AG | 74% |
Nuevocor Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 6, 2025 | ||||
| Series A | Jun 18, 2021 |
Key People
Founding team and executive leadership
Nuevocor Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Xora Innovation | Series B, Series A |
| SEEDS Capital | Series B, Series A |
| Highlight Capital | Series B |
| ClavystBio | Series B |
| EDBI | Series B, Series A |
| Angelini Ventures | Series B |
| EVX Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 234% MoM, reaching 2.9K.
- Jul 25, 2026
Monthly visitors grew 108% MoM, reaching 862.
Nuevocor Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nuevocor's valuation, stock price, and market status.
Is Nuevocor a public or private company?
Nuevocor is a private company.
What is the current stock price of Nuevocor?
Nuevocor is a private company with no public stock price. No recent secondary market data is available.
How much is Nuevocor worth (valuation)?
Valuation information for Nuevocor is not publicly available.
Can I buy Nuevocor stock?
Nuevocor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nuevocor's last funding round?
Nuevocor's most recent funding round was Series B on May 6, 2025.
Who are the main investors in Nuevocor?
Key investors in Nuevocor include Angelini Ventures, EVX Ventures, Boehringer Ingelheim Venture Fund, Kurma Partners.
Will Nuevocor IPO soon?
No public IPO plans have been announced for Nuevocor.
How can I track Nuevocor secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nuevocor's secondary market activity and sign up for updates.